WELLINGTON MANAGEMENT GROUP LLP

Position in TMDX — TransMedics Group, Inc.

CIK 902219 Boston, MA

Position in TMDX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$48,360,279

-$4,353,219 QoQ

Shares Held

486,473

+12.3% QoQ

Ownership

1.41%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 86.55197719092324.ToString("F0")% None 13.448022809076763.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $10,802,033,266 across 28 Medical Devices names. TMDX ranks #10 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	27,070,518	$2,779,330,079
2	SYK	Stryker Corp	8,121,707	$2,668,711,698
3	EW	Edwards Lifesciences Corp	22,011,101	$1,762,648,965
4	BSX	Boston Scientific Corp	18,833,406	$1,181,796,224
5	MDT	Medtronic plc	7,525,572	$652,090,810
6	STE	STERIS plc	2,873,365	$635,387,197
7	DXCM	Dexcom Inc	9,326,240	$585,687,870
8	INSP	Inspire Medical Systems, Inc.	2,535,954	$130,804,505

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$48,360,279	486,473	+12.3%	Shares	Defined	2026-05-15
2025-12-31	$52,713,498	433,321	+100.5%	Shares	Defined	2026-02-17
2025-09-30	$24,251,019	216,141	-2.2%	Shares	Defined	2025-11-14
2025-06-30	$29,626,260	221,075	-23.9%	Shares	Defined	2025-08-14
2025-03-31	$19,552,642	290,616	+76.7%	Shares	Defined	2025-05-13
2024-12-31	$10,252,271	164,431	-45.9%	Shares	Defined	2025-02-12
2024-09-30	$47,691,576	303,768	-3.4%	Shares	Defined	2024-11-14
2024-06-30	$47,346,643	314,345	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.